Comparison of the Molecular Profiles of Human Embryonic and Induced Pluripotent Stem Cells of Isogenic Origin

Overview

Journal Stem Cell Res

Publisher Elsevier

Specialty Cell Biology

Date 2013 Dec 31

PMID 24374290

Citations 36

Authors

Barbara S Mallon

Rebecca S Hamilton

Olga A Kozhich

Kory R Johnson

Yang C Fann

Mahendra S Rao

Pamela G Robey

Affiliations

Soon will be listed here.

Abstract

Many studies have compared the genetic and epigenetic profiles of human induced pluripotent stem cells (hiPSCs) to human embryonic stem cells (hESCs) and yet the picture remains unclear. To address this, we derived a population of neural precursor cells (NPCs) from the H1 (WA01) hESC line and generated isogenic iPSC lines by reprogramming. The gene expression and methylation profile of three lines were compared to the parental line and intermediate NPC population. We found no gene probe with expression that differed significantly between hESC and iPSC samples under undifferentiated or differentiated conditions. Analysis of the global methylation pattern also showed no significant difference between the two PSC populations. Both undifferentiated populations were distinctly different from the intermediate NPC population in both gene expression and methylation profiles. One point to note is that H1 is a male line and so extrapolation to female lines should be cautioned. However, these data confirm our previous findings that there are no significant differences between hESCs and hiPSCs at the gene expression or methylation level.

Citing Articles

Proteomic and functional comparison between human induced and embryonic stem cells.

Brenes A, Griesser E, Sinclair L, Davidson L, Prescott A, Singh F Elife. 2024; 13.

PMID: 39540879 PMC: 11563575. DOI: 10.7554/eLife.92025.

Novel human iPSC models of neuroinflammation in neurodegenerative disease and regenerative medicine.

Summers R, Fagiani F, Rowitch D, Absinta M, Reich D Trends Immunol. 2024; 45(10):799-813.

PMID: 39307583 PMC: 11471369. DOI: 10.1016/j.it.2024.08.004.

Evaluation of the safety and efficiency of cytotoxic T cell therapy sensitized by tumor antigens original from T-ALL-iPSC in vivo.

Li W, Zhou M, Wang L, Huang L, Chen X, Sun X Cancer Innov. 2024; 3(1):e95.

PMID: 38948536 PMC: 11212296. DOI: 10.1002/cai2.95.

Epigenetic and Transcriptional Shifts in Human Neural Stem Cells after Reprogramming into Induced Pluripotent Stem Cells and Subsequent Redifferentiation.

Haubenreich C, Lenz M, Schuppert A, Peitz M, Koch P, Zenke M Int J Mol Sci. 2024; 25(6).

PMID: 38542188 PMC: 10969834. DOI: 10.3390/ijms25063214.

Recent advances and current challenges of new approach methodologies in developmental and adult neurotoxicity testing.

Serafini M, Sepehri S, Midali M, Stinckens M, Biesiekierska M, Wolniakowska A Arch Toxicol. 2024; 98(5):1271-1295.

PMID: 38480536 PMC: 10965660. DOI: 10.1007/s00204-024-03703-8.

References

Ebert A, Yu J, Rose Jr F, Mattis V, Lorson C, Thomson J . Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature. 2008; 457(7227):277-80. PMC: 2659408. DOI: 10.1038/nature07677. View

He J, Ma Y, Lee Y, Thomson J, Kamp T . Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res. 2003; 93(1):32-9. DOI: 10.1161/01.RES.0000080317.92718.99. View

Mayshar Y, Ben-David U, Lavon N, Biancotti J, Yakir B, Clark A . Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell. 2010; 7(4):521-31. DOI: 10.1016/j.stem.2010.07.017. View

Guenther M, Frampton G, Soldner F, Hockemeyer D, Mitalipova M, Jaenisch R . Chromatin structure and gene expression programs of human embryonic and induced pluripotent stem cells. Cell Stem Cell. 2010; 7(2):249-57. PMC: 3010384. DOI: 10.1016/j.stem.2010.06.015. View

Doi A, Park I, Wen B, Murakami P, Aryee M, Irizarry R . Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet. 2009; 41(12):1350-3. PMC: 2958040. DOI: 10.1038/ng.471. View

Soldner F, Hockemeyer D, Beard C, Gao Q, Bell G, Cook E . Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell. 2009; 136(5):964-77. PMC: 2787236. DOI: 10.1016/j.cell.2009.02.013. View

Lister R, Pelizzola M, Dowen R, Hawkins R, Hon G, Tonti-Filippini J . Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009; 462(7271):315-22. PMC: 2857523. DOI: 10.1038/nature08514. View

Teichroeb J, Betts D, Vaziri H . Suppression of the imprinted gene NNAT and X-chromosome gene activation in isogenic human iPS cells. PLoS One. 2011; 6(10):e23436. PMC: 3192059. DOI: 10.1371/journal.pone.0023436. View

Hussein S, Batada N, Vuoristo S, Ching R, Autio R, Narva E . Copy number variation and selection during reprogramming to pluripotency. Nature. 2011; 471(7336):58-62. DOI: 10.1038/nature09871. View

10.

Feng Q, Lu S, Klimanskaya I, Gomes I, Kim D, Chung Y . Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells. 2010; 28(4):704-12. DOI: 10.1002/stem.321. View

11.

Smith K, Luong M, Stein G . Pluripotency: toward a gold standard for human ES and iPS cells. J Cell Physiol. 2009; 220(1):21-9. DOI: 10.1002/jcp.21681. View

12.

Chin M, Mason M, Xie W, Volinia S, Singer M, Peterson C . Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell. 2009; 5(1):111-23. PMC: 3448781. DOI: 10.1016/j.stem.2009.06.008. View

13.

Newman A, Cooper J . Lab-specific gene expression signatures in pluripotent stem cells. Cell Stem Cell. 2010; 7(2):258-62. DOI: 10.1016/j.stem.2010.06.016. View

14.

Si-Tayeb K, Noto F, Nagaoka M, Li J, Battle M, Duris C . Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology. 2009; 51(1):297-305. PMC: 2946078. DOI: 10.1002/hep.23354. View

15.

Kozhich O, Hamilton R, Mallon B . Standardized generation and differentiation of neural precursor cells from human pluripotent stem cells. Stem Cell Rev Rep. 2012; 9(4):531-6. PMC: 3375338. DOI: 10.1007/s12015-012-9357-8. View

16.

Yan H, Yuan W, Velculescu V, Vogelstein B, Kinzler K . Allelic variation in human gene expression. Science. 2002; 297(5584):1143. DOI: 10.1126/science.1072545. View

17.

Deng J, Shoemaker R, Xie B, Gore A, LeProust E, Antosiewicz-Bourget J . Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol. 2009; 27(4):353-60. PMC: 2715272. DOI: 10.1038/nbt.1530. View

18.

Wutz A . Epigenetic alterations in human pluripotent stem cells: a tale of two cultures. Cell Stem Cell. 2012; 11(1):9-15. DOI: 10.1016/j.stem.2012.06.012. View

19.

Zhu S, Li W, Zhou H, Wei W, Ambasudhan R, Lin T . Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell. 2010; 7(6):651-5. PMC: 3812930. DOI: 10.1016/j.stem.2010.11.015. View

20.

Hu B, Weick J, Yu J, Ma L, Zhang X, Thomson J . Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A. 2010; 107(9):4335-40. PMC: 2840097. DOI: 10.1073/pnas.0910012107. View